Induction of natural killer T cell–dependent alloreactivity by administration of granulocyte colony–stimulating factor after bone marrow transplantation-Reference-Cited by-同舟云学术

Induction of natural killer T cell–dependent alloreactivity by administration of granulocyte colony–stimulating factor after bone marrow transplantation

Published:2009-03-29 Issue:4 Volume:15 Page:436-441
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Morris Edward S,MacDonald Kelli P A,Kuns Rachel D,Morris Helen M,Banovic Tatjana,Don Alistair L J,Rowe Vanessa,Wilson Yana A,Raffelt Neil C,Engwerda Christian R,Burman Angela C,Markey Kate A,Godfrey Dale I,Smyth Mark J,Hill Geoffrey R

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.1948.pdf

Reference30 articles.

1. Morris, E.S., MacDonald, K.P. & Hill, G.R. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL? Blood 107, 3430–3435 (2006).

2. Ringden, O. et al. Treatment with granulocyte colony–stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J. Clin. Oncol. 22, 416–423 (2004).

3. Khoury, H.J. et al. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood 107, 1712–1716 (2006).

4. Klumpp, T.R., Mangan, K.F., Goldberg, S.L., Pearlman, E.S. & Macdonald, J.S. Granulocyte colony–stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J. Clin. Oncol. 13, 1323–1327 (1995).

5. McQuaker, I.G. et al. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J. Clin. Oncol. 15, 451–457 (1997).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Better clinical outcomes and lower triggering of inflammatory cytokines for allogeneic hematopoietic cell transplant recipients treated in home care versus hospital isolation – the Karolinska experience;Frontiers in Immunology;2024-08-07

2. Hematopoietic stimulants in the treatment and prevention of graft-versus-host disease;Russian Journal of Pediatric Hematology and Oncology;2023-02-02

3. Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma;Aging;2021-06-16

4. Development of a robust reporter gene assay for measuring the bioactivity of OX40‐targeted therapeutic antibodies;Luminescence;2021-03-05

5. Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care;International Journal of Hematology;2021-02-05